Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beccaria

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|June 1, 1988
Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humansR A Liddle, R J Rushakoff, E T Morita, et al.
Metabolic, Pediatric, and Systemic Ophthalmology (New York, N.Y. : 1985)|January 1, 1986
Visual evoked potentials in diabetic teen-agers: influence of metabolic control and relationship with peripheral neuropathyG Comi, V Martinelli, G Galardi, et al.
Acta Diabetologica Latina|April 1, 1987
Evaluation of central nervous conduction by visual evoked potentials in insulin-dependent diabetic children. Metabolic and clinical correlationsG Comi, V Martinelli, G Galardi, et al.
Minerva Pediatrica|July 31, 1987
[Etiopathogenetic hypothesis and new therapeutic prospectives of insulin-dependent diabetes]G Chiumello, F Meschi, L Beccaria, et al.
The Journal of Clinical Investigation|October 1, 1989
Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCKR A Liddle, B J Gertz, S Kanayama, et al.
European Journal of Neurology|October 23, 2018
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's diseaseM Fabbri, M Zibetti, L Beccaria, et al.
Obesity Research|June 9, 1998
Prader-Willi syndrome: relationship of adiposity to plasma leptin levelsA Pietrobelli, D B Allison, M S Faith, et al.
Bone and Mineral|January 1, 1990
Bone mass in young patients with type I diabetesG Weber, L Beccaria, M de'Angelis, et al.
Journal of Endocrinological Investigation|May 9, 2000
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and DiabetologyA Corrias, J Bellone, L Beccaria, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonistR A Liddle, B J Gertz, S Kanayama, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|June 1, 1988
Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humansR A Liddle, R J Rushakoff, E T Morita, et al.
Metabolic, Pediatric, and Systemic Ophthalmology (New York, N.Y. : 1985)|January 1, 1986
Visual evoked potentials in diabetic teen-agers: influence of metabolic control and relationship with peripheral neuropathyG Comi, V Martinelli, G Galardi, et al.
Acta Diabetologica Latina|April 1, 1987
Evaluation of central nervous conduction by visual evoked potentials in insulin-dependent diabetic children. Metabolic and clinical correlationsG Comi, V Martinelli, G Galardi, et al.
Minerva Pediatrica|July 31, 1987
[Etiopathogenetic hypothesis and new therapeutic prospectives of insulin-dependent diabetes]G Chiumello, F Meschi, L Beccaria, et al.
The Journal of Clinical Investigation|October 1, 1989
Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCKR A Liddle, B J Gertz, S Kanayama, et al.
European Journal of Neurology|October 23, 2018
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's diseaseM Fabbri, M Zibetti, L Beccaria, et al.
Obesity Research|June 9, 1998
Prader-Willi syndrome: relationship of adiposity to plasma leptin levelsA Pietrobelli, D B Allison, M S Faith, et al.
Bone and Mineral|January 1, 1990
Bone mass in young patients with type I diabetesG Weber, L Beccaria, M de'Angelis, et al.
Journal of Endocrinological Investigation|May 9, 2000
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and DiabetologyA Corrias, J Bellone, L Beccaria, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonistR A Liddle, B J Gertz, S Kanayama, et al.
Pageof 5